Analytical Data
-
基因名
LRRC34
- Application
-
别名
LRRC34; Leucine-rich repeat-containing protein 34
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q8IZ02
-
表达区间
1-419aa
-
氨基酸序列
MGSSREAARAPARSPAWASTQASTPGAALAVQRESPESGLQKHYSNLCMEKSQKINPFILHILQEVDEEIKKGLAAGITLNIAGNNRLVPVERVTGEDFWILSKILKNCLYINGLDVGYNLLCDVGAYYAAKLLQKQLNLIYLNLMFNDIGPEGGELIAKVLHKNRTLKYLRMTGNKIENKGGMFFAAMLQINSSLEKLDLGDCDLEESTVHVGRMLKENHCLVALHMCKHDIKNSGIQQLCDALYLNSSLRYLDVSCNKITHDGMVYLADVLKSNTTLEVIDLSFNRIENAGANYLSETLTSHNRSLKALSVVSNNIEGEGLVALSQSMKTNLTFSHIYIWGNKFDEATCITYSDLIQMGCLKPDNTDVEPFVVDGRVYLAEVSNGLKKHYYWTSTYGESYDHSSNAGFALVPVGQQP
-
分子量
72.8 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
LRRC34 (Leucine-Rich Repeat Containing 34) is a protein that has garnered attention in recent years due to its potential roles in cellular processes and its implications in various diseases, especially cancers. As a member of the leucine-rich repeat (LRR) protein family, LRRC34 is believed to be involved in protein-protein interactions and signaling pathways that are crucial for cell growth, differentiation, and apoptosis. Initial studies suggest that alterations in LRRC34 expression may influence tumor progression and metastasis, making it a candidate for further investigation as both a biomarker and a therapeutic target. Despite its promising implications, the precise molecular mechanisms and biological functions of LRRC34 remain poorly understood, warranting in-depth research. Understanding the structure, regulation, and interactions of LRRC34 could provide valuable insights into its role in normal physiology and its dysregulation in pathological conditions. Consequently, the development of recombinant LRRC34 protein has become essential for elucidating these aspects, facilitating studies on its functional roles and potential clinical applications. This research could ultimately contribute to better therapeutic strategies for cancers and other diseases associated with LRRC34 dysregulation.
